Payers want to make sure patients are getting biopsies done so they can get on the right therapies, said Bhuvana Sagar, MD, Oncology Consultants.

Dr. Marla Lipsyc-Sharf reviews her recent session at the 2024 SABCS meeting, discussing biopsy approaches and treatment ...

Luis E. Raez, MD, discusses the current liquid biopsy options for patients with lung cancer through assessing circulating tumor DNA. Luis E. Raez, MD, medical director and chief scientific officer at ...

This eBook delves into the science behind first-void urine, exploring its composition, collection methods, and the latest ...

LMNTIC Biotech develops liquid biopsy technology to isolate rare tumor cells in blood LMNTIC Biotech pioneers novel ...

Abu Dhabi health chiefs have hailed the introduction of a blood test for colon cancer as a "game-changer" in the emirate's ...

Oncocyte Corp. (NASDAQ: OCX), a diagnostics technology company, today announced the publication of favorable data regarding its DetermaCNI™ assay. In a paper recently published in the journal Acta ...

In a study involving 43 MBC patients, the liquid biopsy test reclassified three out of five patients who were initially deemed HER2-negative by tissue biopsy as HER2-positive. This discovery ...

BioMark Expands Its Liquid Biopsy Platform Receptor Status for Breast Cancer Vancouver, British Columbia--( - December 10, 2024) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ...

Global Refractory Follicular Lymphoma Diagnostics Market Projected to Reach USD 464.47 Million by 2029 Refractory Follicular ...

PanGIA Biotech–a pioneer in liquid biopsy technology–today announced its first international partnership, collaborating with Canary Oncoceutics (Canar ...